AstraZeneca’s Imfinzi gains FDA approval for LS-SCLC after ADRIATIC trial shows survival benefits. Separate trials explore additional cancer therapies.
FDA Approves AstraZeneca’s Blockbuster Cancer Drug Imfinzi For Aggressive Form Of Lung Cancer
Where Today's News Shapes Tomorrow
